- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
-
- 长期趋势：
已有238家主力机构披露2024-12-31报告期持股数据，持仓量总计3.94亿股，占流通A股39.99%
- 波段诊断：
-
技术面诊股
诊断结果：3.0技术面打败了28%的股票
技术面评分前10的股票
近期的平均成本为9.54元。
平均成本
近期的平均成本为9.54元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"9.54","date":1752134540,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2025.07.11","stock":"0.74","trade":"0.93","ind":"0.61"},{"date":"2025.07.10","stock":"0.43","trade":"1.32","ind":"0.47"},{"date":"2025.07.09","stock":"0.21","trade":"-0.64","ind":"-0.06"},{"date":"2025.07.08","stock":"0.64","trade":"0.54","ind":"1.46"},{"date":"2025.07.07","stock":"-0.74","trade":"-0.55","ind":"-0.70"},{"date":"2025.07.04","stock":"0.43","trade":"0.41","ind":"-0.25"},{"date":"2025.07.03","stock":"1.19","trade":"2.52","ind":"1.17"},{"date":"2025.07.02","stock":"-0.22","trade":"-1.00","ind":"-0.61"},{"date":"2025.07.01","stock":"1.09","trade":"3.49","ind":"0.11"},{"date":"2025.06.30","stock":"0.22","trade":"0.95","ind":"0.83"},{"date":"2025.06.27","stock":"-0.11","trade":"0.71","ind":"0.34"},{"date":"2025.06.26","stock":"-0.76","trade":"-1.17","ind":"-0.48"},{"date":"2025.06.25","stock":"0.22","trade":"-0.56","ind":"1.72"},{"date":"2025.06.24","stock":"0.55","trade":"1.39","ind":"1.68"},{"date":"2025.06.23","stock":"0.66","trade":"1.63","ind":"0.43"},{"date":"2025.06.20","stock":"0.22","trade":"0.13","ind":"-0.47"},{"date":"2025.06.19","stock":"-1.41","trade":"-2.75","ind":"-1.21"},{"date":"2025.06.18","stock":"0.00","trade":"-1.39","ind":"0.24"},{"date":"2025.06.17","stock":"-0.86","trade":"-1.56","ind":"-0.12"},{"date":"2025.06.16","stock":"-0.85","trade":"0.52","ind":"0.41"},{"date":"2025.06.13","stock":"-2.29","trade":"-2.47","ind":"-1.10"}]
仙琚制药,深证成指,化学制药指数
压力支撑
该股压力位为9.51元，支撑位为9.42元。
[{"text":"\u538b\u529b\u4f4d","value":"9.51","date":1752163200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.42","date":1752163200,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了32%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月11日 20:32
| 机构今日流向(万元) | -13.62 | 机构5日流向(万元) | -6099.17 |
| 机构10日流向(万元) | -3736.06 | 机构20日流向(万元) | -16898.24 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少8686.52万股，其中基金净减仓23家，主力净减仓64家，请投资者中长期谨慎为宜。
截止2024-12-31，共238家主力机构（基金231家，保险公司2家，一般法人4家，社保基金1家），持仓量总计39374.08万股，占流通A股39.99%
其中，基金持仓与2024-06-30相比：
增仓：48家 ，增持 1493.93万股
减仓：71家 ，减持 1735.54万股
新出现在主力名单中：99家 ，持有4896.76万股
从主力名单中消失：163家 ，原持有13348.37万股
其中，基金持仓与2024-06-30相比：
增仓：48家 ，增持 1493.93万股
减仓：71家 ，减持 1735.54万股
新出现在主力名单中：99家 ，持有4896.76万股
从主力名单中消失：163家 ，原持有13348.37万股
消息面诊股
诊断结果：5.5消息面打败了14%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 仙琚制药：噻托溴铵吸入喷雾剂药品注册申请获受理
2025-07-11 - 仙琚制药：出口美国销售额占总营业收入的比例较低
2025-07-11 - 仙琚制药：7月10日获融资买入1187.11万元，
2025-07-11 - 仙琚制药：7月9日获融资买入3104.04万元，占
2025-07-10 - 仙琚制药：7月8日获融资买入2408.45万元，占
2025-07-09 - 仙琚制药（截止2025年7月7日）股东人数为460
2025-07-09 - 仙琚制药：截止近期，公司股东约4万6千户
2025-07-08 - 仙琚制药：奥美克松纳正在等待药学阶段的评审
2025-07-08 - 仙琚制药：杭州能可爱心医疗科技有限公司目前主要从事
2025-07-08 - 仙琚制药继续位列“中国医药工业百强榜单”，并荣获2
2025-07-08
消息列表
| 一般消息 | 募资投向 | 预测年新增净利润为:24636.... | 2025-07-08 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-06-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-16 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-05-06 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-24 |
| 利好 | 分红转增 | 10派3元(含税) | 2025-04-24 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-04-24 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-27 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.8行业面打败了95%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，跑赢大盘。
[{"date":"2025.07.11","price":"0.61","value":"0.93"},{"date":"2025.07.10","price":"0.47","value":"1.32"},{"date":"2025.07.09","price":"-0.06","value":"-0.64"},{"date":"2025.07.08","price":"1.46","value":"0.54"},{"date":"2025.07.07","price":"-0.70","value":"-0.55"},{"date":"2025.07.04","price":"-0.25","value":"0.41"},{"date":"2025.07.03","price":"1.17","value":"2.52"},{"date":"2025.07.02","price":"-0.61","value":"-1.00"},{"date":"2025.07.01","price":"0.11","value":"3.49"},{"date":"2025.06.30","price":"0.83","value":"0.95"},{"date":"2025.06.27","price":"0.34","value":"0.71"},{"date":"2025.06.26","price":"-0.48","value":"-1.17"},{"date":"2025.06.25","price":"1.72","value":"-0.56"},{"date":"2025.06.24","price":"1.68","value":"1.39"},{"date":"2025.06.23","price":"0.43","value":"1.63"},{"date":"2025.06.20","price":"-0.47","value":"0.13"},{"date":"2025.06.19","price":"-1.21","value":"-2.75"},{"date":"2025.06.18","price":"0.24","value":"-1.39"},{"date":"2025.06.17","price":"-0.12","value":"-1.56"},{"date":"2025.06.16","price":"0.41","value":"0.52"},{"date":"2025.06.13","price":"-1.10","value":"-2.47"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 广生堂 | 82.03% | 20.76% | 5.0分 |
| 2 | 前沿生物 | 79.09% | 41.43% | 5.7分 |
| 3 | 联环药业 | 53.01% | 38.58% | 5.4分 |
| 4 | 微芯生物 | 47.47% | 9.03% | 5.9分 |
| 5 | 昂利康 | 46.02% | -7.24% | 4.7分 |
| 6 | 上海谊众 | 41.33% | 6.26% | 5.3分 |
| 8 | 海正药业 | 27.43% | 16.90% | 5.9分 |
| 10 | 能特科技 | 21.84% | 5.77% | 5.9分 |
| 12 | 纳微科技 | 17.72% | 11.54% | 6.2分 |
| 14 | 灵康药业 | 14.73% | 5.15% | 5.4分 |
| 16 | 华纳药厂 | 13.80% | 24.44% | 6.0分 |
| 18 | 富士莱 | 13.28% | 7.80% | 4.5分 |
| 20 | 多瑞医药 | 12.97% | 4.24% | 4.4分 |
| 22 | 翰宇药业 | 11.51% | 0.11% | 5.5分 |
| 24 | 新华制药 | 10.61% | 5.01% | 5.1分 |
| 26 | 北大医药 | 9.08% | 0.15% | 4.8分 |
| 28 | 北陆药业 | 8.83% | -7.69% | 4.3分 |
| 30 | *ST赛隆 | 8.19% | 16.12% | 4.6分 |
| 32 | 康芝药业 | 7.84% | 1.62% | 5.1分 |
| 34 | 永安药业 | 7.40% | -9.24% | 4.5分 |
| 36 | 诚意药业 | 7.16% | -4.11% | 5.3分 |
| 38 | 莱美药业 | 6.65% | 3.08% | 5.0分 |
| 40 | 复旦张江 | 6.51% | 1.22% | 5.5分 |
| 42 | 天宇股份 | 6.29% | 2.72% | 5.4分 |
| 44 | 宏源药业 | 6.17% | -2.11% | 3.9分 |
| 46 | 圣诺生物 | 6.04% | -0.57% | 5.1分 |
| 48 | 津药药业 | 5.65% | 2.98% | 5.7分 |
| 50 | 恒瑞医药 | 5.59% | 6.83% | 6.4分 |
| 52 | 赛分科技 | 5.50% | 2.74% | 4.7分 |
| 54 | 华仁药业 | 5.26% | 1.80% | 5.1分 |
| 56 | 共同药业 | 5.16% | 1.23% | 4.9分 |
| 58 | 仟源医药 | 4.97% | 7.69% | 4.9分 |
| 60 | 神奇制药 | 4.80% | 0.89% | 5.4分 |
| 62 | 誉衡药业 | 4.68% | 6.46% | 5.0分 |
| 64 | 奥赛康 | 4.35% | 7.76% | 5.7分 |
| 66 | 富祥药业 | 4.11% | 4.79% | 4.5分 |
| 68 | 华邦健康 | 4.05% | 2.82% | 5.0分 |
| 70 | 德展健康 | 3.96% | 1.49% | 4.3分 |
| 72 | 福元医药 | 3.53% | 5.64% | 5.5分 |
| 74 | 金陵药业 | 3.26% | 1.61% | 4.9分 |
| 76 | 东北制药 | 3.05% | 1.12% | 5.3分 |
| 78 | 金石亚药 | 2.85% | 3.69% | 5.0分 |
| 80 | 同和药业 | 2.30% | 0.00% | 4.6分 |
| 82 | 普洛药业 | 2.13% | 2.77% | 5.4分 |
| 84 | 中关村 | 2.04% | 0.73% | 5.4分 |
| 86 | 国药现代 | 1.75% | 0.27% | 5.3分 |
| 88 | 汉商集团 | 1.62% | 1.27% | 5.1分 |
| 90 | 华海药业 | 1.53% | -9.59% | 5.1分 |
| 92 | 司太立 | 1.40% | 1.10% | 5.2分 |
| 94 | 本立科技 | 1.22% | -1.06% | 4.3分 |
| 96 | 九典制药 | 0.93% | 0.12% | 4.3分 |
| 98 | *ST苏吴 | 0.83% | -0.82% | 5.1分 |
| 100 | 人福医药 | 0.61% | -0.23% | 5.2分 |
| 102 | 海南海药 | 0.48% | 3.12% | 4.2分 |
| 104 | 首药控股 | 0.38% | 3.90% | 5.1分 |
| 106 | 罗欣药业 | 0.20% | 0.82% | 4.7分 |
| 108 | 海森药业 | 0.00% | -0.56% | 4.6分 |
| 110 | - | 0.00% | -0.29% | 分 |
| 112 | *ST三圣 | -0.40% | 0.40% | 4.1分 |
| 114 | 艾力斯 | -0.57% | 0.21% | 5.2分 |
| 116 | 新和成 | -0.68% | 0.09% | 5.1分 |
| 118 | 复星医药 | -0.81% | 0.67% | 5.2分 |
| 120 | ST景峰 | -1.00% | 1.88% | 4.7分 |
| 122 | 华润双鹤 | -1.16% | 0.76% | 5.0分 |
| 124 | 浙江医药 | -1.67% | -0.13% | 5.2分 |
| 126 | 溢多利 | -1.97% | -1.06% | 4.3分 |
| 128 | 川宁生物 | -2.18% | -0.98% | 4.5分 |
| 130 | 健友股份 | -3.09% | -1.26% | 4.7分 |
| 132 | 东诚药业 | -3.23% | -3.62% | 4.3分 |
| 134 | 海思科 | -4.52% | -0.94% | 4.9分 |
| 136 | 新天地 | -5.87% | 0.00% | 4.1分 |
| 138 | 千红制药 | -7.62% | 2.72% | 5.0分 |
| 140 | 科伦药业 | -9.68% | -8.61% | 4.0分 |
| 142 | 华东医药 | -9.92% | -1.57% | 4.8分 |
| 144 | 苑东生物 | -10.74% | -3.82% | 4.7分 |
| 146 | 力生制药 | -12.21% | 0.00% | 4.9分 |
| 148 | 新诺威 | -13.76% | -3.07% | 4.3分 |
| 150 | 信立泰 | -18.12% | -5.10% | 4.4分 |
| 152 | - | -23.69% | 0.00% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 45/227 ， 63/227。
[{"date":"2025-03-31","value":"2.42","vol":"-0.17"},{"date":"2024-12-31","value":"6.83","vol":"19.44"},{"date":"2024-09-30","value":"8.99","vol":"4.58"},{"date":"2024-06-30","value":"5.87","vol":"3.53"},{"date":"2024-03-31","value":"2.58","vol":"2.30"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.42 | 6.83 | 8.99 | 5.87 | 2.58 |
| 行业(%) | -0.17 | 19.44 | 4.58 | 3.53 | 2.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"55.36","vol":"49.23"},{"date":"2024-12-31","value":"57.49","vol":"51.10"},{"date":"2024-09-30","value":"54.63","vol":"50.51"},{"date":"2024-06-30","value":"54.84","vol":"50.84"},{"date":"2024-03-31","value":"55.11","vol":"50.75"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
55.36 | 57.49 | 54.63 | 54.84 | 55.11 |
| 行业(%) | 49.23 | 51.10 | 50.51 | 50.84 | 50.75 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 77/227 ， 82/227。
[{"date":"2025-03-31","value":"-2.86","vol":"-0.86"},{"date":"2024-12-31","value":"-2.98","vol":"17.58"},{"date":"2024-09-30","value":"-0.01","vol":"45.26"},{"date":"2024-06-30","value":"0.93","vol":"705.46"},{"date":"2024-03-31","value":"8.42","vol":"744.46"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-2.86 | -2.98 | -0.01 | 0.93 | 8.42 |
| 行业(%) | -0.86 | 17.58 | 45.26 | 705.46 | 744.46 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-4.72","vol":"-21.71"},{"date":"2024-12-31","value":"-29.46","vol":"-40.60"},{"date":"2024-09-30","value":"12.42","vol":"-0.63"},{"date":"2024-06-30","value":"12.56","vol":"8.83"},{"date":"2024-03-31","value":"13.53","vol":"18.72"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-4.72 | -29.46 | 12.42 | 12.56 | 13.53 |
| 行业(%) | -21.71 | -40.60 | -0.63 | 8.83 | 18.72 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 30/227 ， 85/227。
[{"date":"2025-03-31","value":"0.14","vol":"0.10"},{"date":"2024-12-31","value":"0.57","vol":"0.43"},{"date":"2024-09-30","value":"0.47","vol":"0.33"},{"date":"2024-06-30","value":"0.31","vol":"0.23"},{"date":"2024-03-31","value":"0.15","vol":"0.12"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.57 | 0.47 | 0.31 | 0.15 |
| 行业(次) | 0.10 | 0.43 | 0.33 | 0.23 | 0.12 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.49","vol":"0.67"},{"date":"2024-12-31","value":"1.83","vol":"3.23"},{"date":"2024-09-30","value":"1.62","vol":"2.17"},{"date":"2024-06-30","value":"1.03","vol":"1.51"},{"date":"2024-03-31","value":"0.52","vol":"0.74"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.49 | 1.83 | 1.62 | 1.03 | 0.52 |
| 行业(次) | 0.67 | 3.23 | 2.17 | 1.51 | 0.74 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"1.83","vol":"-28.86"},{"date":"2024-12-31","value":"23.73","vol":"-368.97"},{"date":"2024-09-30","value":"11.11","vol":"-9.88"},{"date":"2024-06-30","value":"-1.25","vol":"-252.28"},{"date":"2024-03-31","value":"10.50","vol":"-3.76"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 1.83 | 23.73 | 11.11 | -1.25 | 10.50 |
| 行业 | -28.86 | -368.97 | -9.88 | -252.28 | -3.76 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.91","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.95","vol":"2.19"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.91 | - | 0.95 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.19 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 118/227 ， 117/227。
[{"date":"2025-03-31","value":"4.64","vol":"3.59"},{"date":"2024-12-31","value":"4.19","vol":"3.32"},{"date":"2024-09-30","value":"4.34","vol":"3.67"},{"date":"2024-06-30","value":"3.28","vol":"3.60"},{"date":"2024-03-31","value":"3.14","vol":"3.71"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.64 | 4.19 | 4.34 | 3.28 | 3.14 |
| 行业 | 3.59 | 3.32 | 3.67 | 3.60 | 3.71 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"3.27","vol":"2.81"},{"date":"2024-12-31","value":"2.94","vol":"2.62"},{"date":"2024-09-30","value":"3.02","vol":"2.92"},{"date":"2024-06-30","value":"2.21","vol":"2.89"},{"date":"2024-03-31","value":"2.29","vol":"3.06"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.27 | 2.94 | 3.02 | 2.21 | 2.29 |
| 行业 | 2.81 | 2.62 | 2.92 | 2.89 | 3.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 116/227 ， 121/227。
[{"date":"2025-03-31","value":"14.80","vol":"33.96"},{"date":"2024-12-31","value":"15.88","vol":"34.28"},{"date":"2024-09-30","value":"12.15","vol":"32.89"},{"date":"2024-06-30","value":"15.83","vol":"33.06"},{"date":"2024-03-31","value":"17.12","vol":"32.53"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.80 | 15.88 | 12.15 | 15.83 | 17.12 |
| 行业(%) | 33.96 | 34.28 | 32.89 | 33.06 | 32.53 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.17","vol":"1.46"},{"date":"2024-12-31","value":"0.19","vol":"0.84"},{"date":"2024-09-30","value":"0.14","vol":"0.72"},{"date":"2024-06-30","value":"0.19","vol":"0.70"},{"date":"2024-03-31","value":"0.21","vol":"0.69"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.17 | 0.19 | 0.14 | 0.19 | 0.21 |
| 行业(%) | 1.46 | 0.84 | 0.72 | 0.70 | 0.69 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 浙商证券 | 2025-05-20 | 买入 | |
| 西部证券 | 2025-05-16 | 买入 | |
| 华泰金融(HK) | 2025-04-30 | 买入 | |
| 民生证券 | 2025-04-28 | 买入 | |
| 东方证券 | 2025-04-28 | 买入 | |
| 中国银河 | 2025-04-28 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"6.19","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.49","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.63","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.97","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.30","blueLineValue":"0.64","type":"YC"}]